EP4173612A1 - Zusammensetzungen zur verwendung in der hautpflege - Google Patents

Zusammensetzungen zur verwendung in der hautpflege Download PDF

Info

Publication number
EP4173612A1
EP4173612A1 EP21306507.1A EP21306507A EP4173612A1 EP 4173612 A1 EP4173612 A1 EP 4173612A1 EP 21306507 A EP21306507 A EP 21306507A EP 4173612 A1 EP4173612 A1 EP 4173612A1
Authority
EP
European Patent Office
Prior art keywords
composition
weight
total composition
butter
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21306507.1A
Other languages
English (en)
French (fr)
Inventor
Marjorie Lefebvre
Cécile Marie Geslin
Julie Potier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
Johnson and Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Consumer Inc filed Critical Johnson and Johnson Consumer Inc
Priority to EP21306507.1A priority Critical patent/EP4173612A1/de
Priority to CN202280072301.8A priority patent/CN118159243A/zh
Priority to PCT/IB2022/060309 priority patent/WO2023073590A1/en
Priority to CA3236775A priority patent/CA3236775A1/en
Publication of EP4173612A1 publication Critical patent/EP4173612A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Definitions

  • the composition comprises:
  • Lotions and creams can be formulated as emulsions.
  • Such lotions contain from 0.5% to about 5% of an emulsifier(s), while such creams would typically contain from about 1% to about 20% (e.g., from about 5% to about 10%) of an emollient(s); from about 20% to about 80% (e.g., from 30% to about 70%) of water; and from about 1% to about 10% (e.g., from about 2% to about 5%) of an emulsifier(s).
  • the composition is substantially free of C16 fatty alcohols, C18 fatty alcohols, or mixtures of C16/C18 alcohols.
  • cetearyl alcohol which is a mixture of cetyl (C16) alcohol and stearyl (C18) alcohol is preferably not present in the composition according to the invention.
  • compositions described herein comprise one or more emollients comprising at least one natural butter having a natural butter which is solid at 20°C and has a melting point below 50°C .
  • an "emollient” is a compound that helps to maintain the soft, smooth, and pliable appearance of the skin (e.g., by remaining on the skin surface or in the stratum corneum to act as a lubricant).
  • suitable emollients include those found in Chapter 35, pages 399-415 (Skin Feel Agents, by G Zocchi) in Handbook of Cosmetic Science and Technology (edited by A. Barel, M. Paye and H. Maibach, Published in 2001 by Marcel Dekker, Inc New York, NY ).
  • the composition preferably contains more of the one or more C 20-24 fatty alcohols than the at least one natural butter. They may be present in a ratio of about 0.5 to about 2, or about 0.5 to about 1.8, or about 0.6 to about 1.5, or more preferably 1.5 of C 20-24 fatty alcohols to the at least one natural butter.
  • the C 20-24 fatty alcohols comprise behenyl alcohol and the emollient comprises shea butter. They may be present in a ratio of about 0.5 to about 2, or about 0.5 to about 1.8, or about 0.6 to about 1.5, or more preferably 1.5 of behenyl alcohol to shea butter.
  • the shea butter and behenyl alcohol are present in a total amount of about 3 to about 7 wt.%, or about 4 to about 6 wt.%, or about 5 wt.%.
  • One suitable nonionic surfactant is the polyoxyethylene derivatives of polyol esters, wherein the polyoxyethylene derivative of polyol ester (1) is derived from (a) a fatty acid containing from about 8 to about 22, and preferably from about 10 to about 14 carbon atoms, and (b) a polyol selected from sorbitol, sorbitan, glucose, ⁇ -methyl glucoside, polyglucose having an average of about 1 to about 3 glucose residues per molecule, glycerin, pentaerythritol and mixtures thereof, (2) contains an average of from about 10 to about 120, and preferably about 20 to about 80 oxyethylene units; and (3) has an average of about 1 to about 3 fatty acid residues per mole of polyoxyethylene derivative of polyol ester.
  • the polyoxyethylene derivative of polyol ester (1) is derived from (a) a fatty acid containing from about 8 to about 22, and preferably from about 10 to about 14 carbon atoms, and (b) a
  • Suitable nonionic surfactants includes long chain alkyl glucosides or polyglucosides, which are the condensation products of (a) a long chain alcohol containing from about 6 to about 22, and preferably from about 8 to about 14 carbon atoms, with (b) glucose or a glucose-containing polymer.
  • the alkyl gluocosides have about 1 to about 6 glucose residues per molecule of alkyl glucoside.
  • a preferred glucoside is decyl glucoside, which is the condensation product of decyl alcohol with a glucose polymer and is available commercially from Henkel Corporation of Hoboken, N.J. under the tradename, "Plantaren 2000.”
  • the nonionic surfactant is selected from the group consisting of alkyl glucosides (e.g., decyl glucoside, lauryl glucoside, coco-glucoside) PEG-80, sorbitan Laurate and combinations thereof.
  • alkyl glucosides e.g., decyl glucoside, lauryl glucoside, coco-glucoside
  • PEG-80 sorbitan Laurate and combinations thereof.
  • suitable pearlescent or opacifying agents include, but are not limited to mono or diesters of (a) fatty acids having from about 16 to about 22 carbon atoms and (b) either ethylene or propylene glycol; mono or diesters of (a) fatty acids having from about 16 to about 22 carbon atoms (b) a polyalkylene glycol of the formula: HO-(JO)a—H, wherein J is an alkylene group having from about 2 to about 3 carbon atoms; and a is 2 or 3; fatty alcohols containing from about 16 to about 22 carbon atoms; fatty esters of the formula: KCOOCH2L, wherein K and L independently contain from about 15 to about 21 carbon atoms; inorganic solids insoluble in the composition, and mixtures thereof.
  • humectants Any of a variety of commercially available humectants, which are capable of providing moisturization and conditioning properties to the composition, are suitable for use in the present invention. What is meant by a humectant is a compound intended to increase the water content of the top layers of skin (e.g., hygroscopic compounds). Examples of suitable humectants include those found in Chapter 35, pages 399-415 (Skin Feel Agents, by G Zocchi) in Handbook of Cosmetic Science and Technology (edited by A. Barel, M. Paye and H.
  • the humectant may be present in an amount of from 1% to 10 %, preferably 4% to 6%, preferably about 5%, by weight % of the total composition.
  • humectants nonexclusively include: 1) water soluble liquid polyols selected from the group comprising glycerine, propylene glycol, hexylene glycol, butylene glycol, dipropylene glycol, polyglycerols, and mixtures thereof; 2) polyalkylene glycol of the formula: HO-(R"O)b-H, wherein R" is an alkylene group having from about 2 to about 3 carbon atoms and b is an integer of from about 2 to about 10; 3) polyethylene glycol ether of methyl glucose of formula CH3-C6H10O5-(OCH2CH2)c-OH, wherein c is an integer from about 5 to about 25; 4) urea; and 5) mixtures thereof.
  • the humectant is preferably chosen from glycerin.
  • the benefit agents useful herein may be categorized by their therapeutic benefit or their postulated mode of action. However, it is to be understood that the benefit agents useful herein may, in some circumstances, provide more than one therapeutic benefit or operate via greater than one mode of action. Therefore, the particular classifications provided herein are made for the sake of convenience and are not intended to limit the benefit agents to the particular application(s) listed.
  • the compounds, which are identified below as being suitable for use as benefit agents may be used in an amount over and above the amount that they may be used for other purposes in the composition or personal care system.
  • Suitable benefit agents include, but are not limited to, depigmentation agents; reflectants; film forming polymers; humectants; amino acids and their derivatives; antimicrobial agents; allergy inhibitors; anti-acne agents; anti-aging agents; anti-wrinkling agents, antiseptics; analgesics; antitussives; antipruritics; local anesthetics; anti-hair loss agents; hair growth promoting agents; hair growth inhibitor agents, antihistamines such as Mandragora Vernalis, Tanacetum Parthenium and the like; antiinfectives such as Acacia Catechu, Aloe Barbadensis, Convallaria Majalis, Echinacea, Eucalyptus, Mentha Piperita, Rosa Canina, Sassafras Albidum, and the like; inflammation inhibitors; anti-emetics; anticholinergics; vasoconstrictors; vasodilators; wound healing promoters; peptides
  • Suitable anti-edema agents nonexclusively include bisabolol natural, synthetic bisabolol, and mixtures thereof.
  • vasoconstrictors nonexclusively include horse chestnut extract, prickly ash, and mixtures thereof.
  • suitable anti-inflammatory agents nonexclusively include benoxaprofen, centella asiatica, bisabolol, feverfew (whole), feverfew (parthenolide free), green tea extract, green tea concentrate, hydrogen peroxide, lycopene including "Lyc-o-Pen” available from LycoRed Natural Products Industries, Ltd., oat oil, chamomile, and mixtures thereof.
  • suitable anti-inflammatory agents nonexclusively include benoxaprofen, centella asiatica, bisabolol, feverfew (whole), feverfew (parthenolide free), green tea extract, green tea concentrate, hydrogen peroxide, lycopene including "Lyc-o-Pen” available from LycoRed Natural Products Industries, Ltd., oat oil, chamomile, and mixtures thereof.
  • collagen enhancers nonexclusively include vitamin A, vitamin C, and mixtures thereof.
  • Suitable skin firming agent nonexclusively include dimethylaminoethanol (“DMAE").
  • suitable antipruritics and skin protectants nonexclusively include oatmeal, betaglucan, feverfew, soy and derivatives thereof, bicarbonate of soda, colloidal oatmeal, surfactant based colloidal oatmeal cleanser, Anagallis Arvensis, Oenothera Biennis, Verbena Officinalis, and the like. These antipruritics may be used in an amount, based upon the total weight of the composition, from about 0.01 percent to about 40 percent, and preferably from about 1 percent to about 5 percent.
  • Suitable reflectants nonexclusively include mica, alumina, calcium silicate, glycol dioleate, glycol distearate, silica, sodium magnesium fluorosilicate, and mixtures thereof.
  • Suitable film forming polymers include acetyl tyrosinamide, zinc pyrithione, coal tar, benzoyl peroxide, selenium sulfide, hydrocortisone, sulfur, menthol, pramoxine hydrochloride, tricetylmonium chloride, polyquaternium 10, panthenol, panthenol triacetate, vitamin A and derivatives thereof, vitamin B and derivatives thereof, vitamin C and derivatives thereof, vitamin D and derivatives thereof, vitamin E and derivatives thereof, vitamin K and derivatives thereof, keratin, lysine, arginine, hydrolyzed wheat proteins, hydrolyzed silk proteins, octyl methoxycinnamate, oxybenzone, minoxidil, titanium dioxide, zinc dioxide, reti
  • benefit agent includes those therapeutic components that are effective in the treatment of dandruff, seborrheic dermatitis, and psoriasis as well as the symptoms associated therewith.
  • suitable benefits agents nonexclusively include zinc pyrithione, anthralin, shale oil and derivatives thereof such as sulfonated shale oil, selenium sulfide, sulfur; salicylic acid; coal tar; povidone-iodine, imidazoles such as ketoconazole, dichlorophenyl imidazolodioxalan, which is commercially available from Janssen Pharmaceutica, N.V., under the tradename, "Elubiol", clotrimazole, itraconazole, miconazole, climbazole, tioconazole, sulconazole, butoconazole, fluconazole, miconazole nitrate and any possible stereo isomers and derivatives thereof; piroctone ol
  • vitamin A analogs such as esters of vitamin A, e.g. vitamin A palmitate, retinoids, retinols, and retinoic acid
  • corticosteroids such as hydrocortisone, clobetasone, butyrate, clobetasol propionate and mixtures thereof.
  • composition may be applied topically. Such topical application may be to any skin in need of treatment on the body, for example skin of the face, lips, neck, chest, back, buttocks, arms, axilla, and/or legs.
  • the composition may also be administered to a mucous membrane (i.e., in the oral cavity).
  • the present invention is in the form of a substrate comprising a composition of the present invention.
  • Any suitable substrate may be used. Examples of suitable substrates and substrate materials are disclosed, for example, in US7452547 and US2009/0241242 which are incorporated herein by reference in their entirety.
  • the composition is in the form of a tablet, pill, or capsule. In one or more embodiments, the composition is in the form of a solution, suspension, emulsion, lotion, cream, serum, gel, stick, spray, ointment, liquid wash, soap bar, shampoo, hair conditioner, paste, foam, powder, mousse, shaving cream, hydrogel, or film-forming product.
  • the composition may be applied directly from a package to the skin in need, by hand to the skin in need, or may be transferred from a substrate such as a wipe or mask, or a combination of two or more thereof.
  • the composition may be applied via a dropper, tube, roller, spray, and patch or added to a bath or otherwise to water to be applied to the skin, and the like.
  • the composition may be applied in a variety of manners or forms, including, without limitation, as a leave-on cream, mask, and /or serum.
  • composition comprises:
  • essentially free or “substantially free” of an ingredient means containing less than 0.1 weight percent, or less than 0.01 weight percent, or none of an ingredient.
  • Viscosities were measured with a rheometer (Physica) at 20°C, with a shear rate at 45s -1 . Viscosity is an important feature to skin care formulas, as they must have the right consistency to be pleasing to the consumer, while also being able to be dispensed correctly (e.g., being able to be pumped). Generally speaking, a viscosity range of about 400 to about 5000 mPa.s -1 is considered acceptable for a skin care composition, or an upper limit of 3,000 mPa.s -1 for a pumpable skin care composition. Comparative examples INCI Name (active matter %) Ex. 1 Ex. 2 Ex. 3 Ex. 4 Ex.
  • Example 2 Considered to be comparative because it did not contain at least one natural butter having a natural butter which is solid at 20°C and has a melting point below 50°C.
  • - Example 3 Considered to be comparative in some embodiments because the ratio of behenyl alcohol to shea butter is 3.
  • Examples 4 & 5 Considered to be comparative because it did not contain one or more thickening polysaccharides comprising succinoglycan.
  • INCI Name % active matter

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
EP21306507.1A 2021-10-27 2021-10-27 Zusammensetzungen zur verwendung in der hautpflege Pending EP4173612A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP21306507.1A EP4173612A1 (de) 2021-10-27 2021-10-27 Zusammensetzungen zur verwendung in der hautpflege
CN202280072301.8A CN118159243A (zh) 2021-10-27 2022-10-26 适用于护肤的组合物
PCT/IB2022/060309 WO2023073590A1 (en) 2021-10-27 2022-10-26 Compositions suitable for use in skin care
CA3236775A CA3236775A1 (en) 2021-10-27 2022-10-26 Compositions suitable for use in skin care

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21306507.1A EP4173612A1 (de) 2021-10-27 2021-10-27 Zusammensetzungen zur verwendung in der hautpflege

Publications (1)

Publication Number Publication Date
EP4173612A1 true EP4173612A1 (de) 2023-05-03

Family

ID=78592793

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21306507.1A Pending EP4173612A1 (de) 2021-10-27 2021-10-27 Zusammensetzungen zur verwendung in der hautpflege

Country Status (4)

Country Link
EP (1) EP4173612A1 (de)
CN (1) CN118159243A (de)
CA (1) CA3236775A1 (de)
WO (1) WO2023073590A1 (de)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063397A (en) 1996-10-25 2000-05-16 The Procter & Gamble Company Disposable cleansing products for hair and skin
US7452547B2 (en) 2004-03-31 2008-11-18 Johnson&Johnson Consumer Co., Inc. Product for treating the skin comprising a polyamine microcapsule wall and a skin lightening agent
US20090241242A1 (en) 2008-03-31 2009-10-01 Heidi Beatty Facial mask
US20210093529A1 (en) * 2019-09-30 2021-04-01 Concept Matrix Solutions Topical sunscreen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063397A (en) 1996-10-25 2000-05-16 The Procter & Gamble Company Disposable cleansing products for hair and skin
US7452547B2 (en) 2004-03-31 2008-11-18 Johnson&Johnson Consumer Co., Inc. Product for treating the skin comprising a polyamine microcapsule wall and a skin lightening agent
US20090241242A1 (en) 2008-03-31 2009-10-01 Heidi Beatty Facial mask
US20210093529A1 (en) * 2019-09-30 2021-04-01 Concept Matrix Solutions Topical sunscreen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 15 January 2021 (2021-01-15), ANONYMOUS: "97% Natural Soothing Lotion", XP055909950, retrieved from https://www.gnpd.com/sinatra/recordpage/8413641/ Database accession no. 8413641 *
DATABASE GNPD [online] MINTEL; 30 January 2020 (2020-01-30), ANONYMOUS: "Overnight Firming Treatment", XP055909820, retrieved from https://www.gnpd.com/sinatra/recordpage/7210747/ Database accession no. 7210747 *
G ZOCCHI: "Handbook of Cosmetic Science and Technology", 2001, MARCEL DEKKER, INC, article "Skin Feel Agents", pages: 399 - 415

Also Published As

Publication number Publication date
CN118159243A (zh) 2024-06-07
CA3236775A1 (en) 2023-05-04
WO2023073590A1 (en) 2023-05-04

Similar Documents

Publication Publication Date Title
CN110403833B (zh) 用于增强碱性有益剂的局部施用的组合物及方法
RU2537235C2 (ru) Мягко действующие несмываемые композиции для ухода за кожей
US9775344B2 (en) High alcohol content sanitizer
JPH09241156A (ja) 血流促進剤及びこれを配合して成る皮膚外用剤
JP5550863B2 (ja) 化粧料
WO2010105050A1 (en) Thickening additive compositions
JP2013107862A (ja) ジェル状皮膚化粧料
KR20190105383A (ko) 자가발포 기능을 갖는 화장료 조성물
JP2013209313A (ja) 乳化型皮膚外用剤
KR102610937B1 (ko) 가교 히알루론산 조성물 및 이의 제조방법
JPH0995432A (ja) 皮膚外用剤
JP2021088523A (ja) 皮膚化粧料
JP2019077675A (ja) ジェル状皮膚外用剤又は皮膚化粧料
EP4173612A1 (de) Zusammensetzungen zur verwendung in der hautpflege
EP2198828A2 (de) Verdünnte strukturierte Zusammensetzung mit verzweigtem Fettalkohol
JP3479048B2 (ja) 化粧料及び不織布含浸化粧料
JP2024538277A (ja) スキンケアにおける使用に好適な組成物
JPH10279427A (ja) 保湿化粧料組成物
JP7546113B1 (ja) 水中油型乳化化粧料
JPH08268866A (ja) 皮膚外用剤
WO2022137030A1 (en) Compositions comprising cocamidopropyl betaine and at least one fatty acid
JPH07215832A (ja) 皮膚外用剤
RU2816954C2 (ru) Средство для интимной гигиены
JP2024078236A (ja) 結晶析出抑制剤
JP2024084391A (ja) 肌のきしみ抑制剤

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: JOHNSON & JOHNSON CONSUMER INC.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40089236

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20231011

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS